CADRENAL THERAPEUTICS, INC.
Profile
Company Names
CADRENAL THERAPEUTICS, INC.
Addresses
822 A1A NORTH, SUITE 306, PONTE VEDRA, FL 32082
822 A1A NORTH, SUITE 306, PONTE VEDRA, FL 32082
822 A1A NORTH, SUITE 300, PONTE VEDRA, FL 32082
Phone Numbers
(904) 900-0701
(904) 300-0701
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2022
State Incorporated:
DELAWARE
Total Amount Raised:
$29,648,159.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2026-04-01
$7,923,235.00
$7,923,235.00
$0.00
5
2025-12-16
$4,396,329.00
$4,396,329.00
$0.00
4
2024-11-01
$9,428,594.00
$9,428,594.00
$0.00
3
2023-07-14
$7,500,001.00
$7,500,001.00
$0.00
2
2022-11-30
$250,000.00
$1,000,000.00
$750,000.00
Debt
1
2022-07-12
$150,000.00
$2,000,000.00
$1,850,000.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY
COLE
EXECUTIVE OFFICER
JAMES
FERGUSON
EXECUTIVE OFFICER
DOUGLAS
LOSORDO
EXECUTIVE OFFICER
JOHN
MURPHY
DIRECTOR
U.S. SELECT REO FUND I, LLC
| NDSSI HOLDINGS LLC
| RESIDENTIAL FORECLOSURE FUND II, LLC
| NEUWAVE MEDICAL, INC.
| PAUL DAVIS NATIONAL, LLC
| APEX SPORTS GROUP, LLC
| SUMMIT MATERIALS HOLDINGS L.P.
| SITELOCK, LLC
| INTERNATIONAL COMMUNICATIONS CORP INC.
| TRI-D TECHNOLOGIES INC.
| VIRTUAL INCISION CORP
| MARYLAND PROGRESSIVE HEALTH, LLC
| ANFIELD GOLD CORP.
| BGOOD LLC
| PJ CLARKES AT THE CURTIS, LLC
| INZINC MINING LTD.
| HYPERPLANE (SPV-V), L.P.
| LINKSQUARES, INC.
| PICKLE ROBOT CO
| SENSIBLE ORGANICS, INC.
| SW-B. RILEY RETAIL OPPORTUNITY FUND, LLC
| ARBOR BIOTECHNOLOGIES, INC.
| SPORTS VISIO, INC.
| HYPERPLANE OPPORTUNITIES I, LP
| CADRENAL THERAPEUTICS, INC.
| COSELL, INC.
| NEXAMP, INC.
| DILL SPV, LP
| CASTLEROCK BIOFUELS, LLC
JOHN
R.
MURPHY
DIRECTOR
MATTHEW
SZOT
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2022-11-30
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2022-07-12

